Trial intelligence / Profile preview

Remimazolam vs Propofol for Stress Response and Postoperative Cognitive Function in Elderly ERCP Patients

ChiCTR2500111750Phase 4Completed

Sponsor
Shandong Provincial Third Hospital
Start
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in choledocholithiasis comparing Remimazolam group with Propofol group (2 arms). Primary endpoint: Mini Mental State Examination score. Started Nov 2025; status: completed.

02

Drugs

remimazolampropofol
03

Conditions

choledocholithiasis

Beyond the preview

Go deeper on ChiCTR2500111750.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500111750.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call